The Barbara Ann Karmanos Cancer Institute and Wayne State University will host the Sixth Annual Lymphoma Symposium on Saturday, Aug. 3. This year’s symposium will feature lymphoma specialists from Memorial Sloan Kettering Cancer Center, the National Cancer Institute, Columbia University, and more, in addition to Karmanos experts.
“As program director, I look forward to hosting the annual symposium each year,” said Dipenkumar Modi, M.D., hematologist, medical oncologist, and member of the Bone Marrow and Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams (MDTs). “At this event, we bring experts into one room to share research, progress of clinical trials, expertise, and the latest treatment options for lymphoma patients. It’s also an opportunity for health care providers to network and learn about advances in lymphoma and the options that may be best for their patients.”
Topics covered during this year’s symposium include chronic lymphocytic leukemia, follicular lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma, primary CNS lymphoma, CAR T-cell therapy in treating lymphoma, T-cell non-Hodgkin lymphoma, Hodgkin lymphoma, and stem cell transplant for the treatment of lymphoma. Dr. Modi has invited multiple experts from across the country, including Pallawi Torka, M.D., and Gilles Salles, M.D., Ph.D., from Memorial Sloan Kettering; Mark Roschewski, M.D., from the National Cancer Institute and the National Institutes of Health; Barbara Pro, M.D., from Columbia University; and Rod Ramchandren, M.D., from The University of Tennessee.
During last year’s symposium, two highlights emerged.
“We learned that bispecific T-cell engager (BiTE) agents such as epcoritamab and glofitamab have shown encouraging activity in diffuse large B-cell lymphoma (DLBCL) and are approved for use in patients after two or more lines of systemic therapy. We also learned that consolidation autologous stem cell transplants have been shown to improve progression-free and overall survival for primary CNS lymphoma and should be offered to young and medically fit patients,” explained Dr. Modi.
This year’s Lymphoma Symposium also features three case discussions and presentations from the following Karmanos experts and members of the Bone Marrow and Stem Cell Transplant and Hematology Oncology MDTs: Abhinav Deol, M.D., Joseph Uberti, M.D., Ph.D., and Jay Yang, M.D.
Attendees may claim a maximum of 6.25 AMA PRA Category 1 Credit(s)™, depending on their extent of participation during the event.
Registration is required. The cost is $60 for physicians; $30 for retired physicians, pharmacists, mid-level providers, nurses, CTO staff and allied health providers; and $20 for fellows, residents and medical students. The deadline to register is Thursday, Aug. 1. Register online at karmanos.org/lymphomasymposium. For additional information, contact Pamelia Sydorchuk, symposium coordinator, at symposium@karmanos.org or 313-576-8746.
